No evidence for severe retinopathy of prematurity following sildenafil [14]

British Journal of Ophthalmology

Volumn 89, Issue 2, 2005, Pages 250-

  Pierce, C M ^a   Petros, A J ^a   Fielder, A R ^b  

^a GREAT ORMOND STREET HOSPITAL   (United Kingdom)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

NITRIC OXIDE; SILDENAFIL;

ARTIFICIAL VENTILATION; CASE REPORT; CHOROID; DRUG EFFECT; FOLLOW UP; HUMAN; INFANT; LETTER; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RETINA BLOOD VESSEL; RETROLENTAL FIBROPLASIA; VASODILATATION;

HUMANS; HYPERTENSION, PULMONARY; INFANT, NEWBORN; PIPERAZINES; RETINOPATHY OF PREMATURITY; VASODILATOR AGENTS;

EID: 12944304593     PISSN: 00071161     EISSN: None     Source Type: Journal    
DOI: 10.1136/bjo.2004.054023     Document Type: Letter

References (4)

1. Marsh CS, Morden B, Newsom R. Severe retinopathy of prematurity (ROP) in a premature baby treated with sildenafil acetate (Viagra) for pulmonary hypertension. Br J Ophthalmol 2004;84:306-7.
2. Rache M, Meyer P, Prünte C, et al. Sildenafil induces retinal vasodilatation in healthy subjects. Br J Ophthalmol 2002;86:156-8.
3. Grunwald JE, Siu KK, Jacob SS, et al. Effect of sildenafil (Viagra) on the ocular circulation. Am J Ophthalmol 2001;131:751-5.
4. Grunwald JE, Metelisina T, Grunwald L. Effect of sildenafil (Viagra) on retinal blood vessel diameter. Am J Ophthalmol 2002;133:809-12.